Drug Discovery Pipeline (DDP), GIBH CAS
China
1 December 2017 - 30 November 2018
Principal institution: Guangzhou Institutes of Biomedicine and Health (GIBH), CAS
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Drug Discovery Pipeline (DDP), GIBH CAS published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 2 | 0.06 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 2 | 0.06 | |
Top articles by Altmetric score in current window
NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming
Nature Cell Biology
2018-03-12
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
